Abstract:Arteriosclerosis, Thrombosis, and Vascular Biology, Ahead of Print. BACKGROUND:The physiopathology of life-threatening cerebrovascular complications in preeclampsia is unknown. We investigated whether disruption of the blood-brain barrier, generated using circulating small extracellular vesicles (sEVs) from women with preeclampsia or placentae cultured under hypoxic conditions, impairs the expression of tight junction proteins, such as CLDN5 (claudin-5), mediated by VEGF (vascular endothelial growth factor), and activation of KDR (VEGFR2 [VEGF receptor 2]).METHODS:We perform a preclinical mechanistic study using sEVs isolated from plasma of pregnant women with normal pregnancy (sEVs-NP; n=9), sEVs isolated from plasma of women with preeclampsia (sEVs-PE; n=9), or sEVs isolated from placentas cultured in normoxia (sEVs-Nor; n=10) or sEVs isolated from placentas cultured in hypoxia (sEVs-Hyp; n=10). The integrity of the blood-brain barrier was evaluated using in vitro (human [hCMEC/D3] and mouse [BEND/3] brain endothelial cell lines) and in vivo (nonpregnant C57BL/6J mice [4–5 months old; n=13] injected with sEVs-Hyp) models.RESULTS:sEVs-PE and sEVs-Hyp reduced total and membrane-associated protein CLDN5 levels (P<0.05). These results were negated with sEVs-PE sonication. sEVs-Hyp injected into nonpregnant mice generated neurological deficits and blood-brain barrier disruption, specifically in the posterior area of the brain, associated with brain endothelial cell uptake of sEVs, sEVs-Hyp high extravasation, and reduction in CLDN5 levels in the brain cortex. Furthermore, sEVs-PE and sEVs-sHyp had higher VEGF levels than sEVs-NP and sEVs-Nor. Human brain endothelial cells exposed to sEVs-PE exhibited a reduction in the activation of KDR. Reduction in CLDN5 observed in cells treated with sEVs-Hyp was further enhanced in cells treated with KDR selective inhibitor.CONCLUSIONS:sEVs-PE disrupts the blood-brain barrier, an effect replicated with sEVs-Hyp, and involves reduced CLDN5 and elevated VEGF contained within these vesicles. However, our results do not support the participation of KDR activation in the downregulation of CLDN5 observed with sEVs-Hyp. These findings will improve our understanding of the pathophysiology of cerebrovascular alterations in women with preeclampsia.

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Extracellular Vesicles From Preeclampsia Disrupt the Blood-Brain Barrier by Reducing CLDN5

Placental hypoxia-induced alterations in vascular function, morphology, and endothelial barrier integrity

Role of Extracellular Vesicles and microRNAs on Dysfunctional Angiogenesis during Preeclamptic Pregnancies

Extracellular Vesicles and Preeclampsia: Current Knowledge and Future Research Directions

hsa-miR-9-5p highly expressed in syncytiotrophoblast-derived extracellular vesicles from early-onset preeclampsia impairs cerebral microvascular endothelial cell pro-angiogenic capacity

Revisiting preeclampsia: a metabolic disorder of the placenta

Placenta-derived extracellular vesicles induce preeclampsia in mouse models

Exosomes from Women with Preeclampsia Induced Vascular Dysfunction by Delivering Sflt (soluble Fms-Like Tyrosine Kinase)-1 and Seng (soluble Endoglin) to Endothelial Cells

Preeclampsia and transport of ions and small molecules: A literature review

Circulating extracellular vesicles and neutrophil extracellular traps contribute to endothelial dysfunction in preeclampsia

Cerebral Biomarkers and Blood-Brain Barrier Integrity in Preeclampsia

Placenta Extracellular Vesicles: Messengers Connecting Maternal and Fetal Systems

OP15.09: Circulating placenta‐derived extracellular vesicles contribute to endothelial dysfunction in pre‐eclampsia

Placental Trophoblast Cell Differentiation: Physiological Regulation and Pathological Relevance to Preeclampsia

Placental Exosomal Mir-125B Triggered Endothelial Barrier Injury in Preeclampsia.

Influence of placental exosomes from early onset preeclampsia women umbilical cord plasma on human umbilical vein endothelial cells

VEGF in the muscular layer of placental blood vessels: immuno-expression in preeclampsia and intrauterine growth restriction and its association with the antioxidant status

Placental Methylglyoxal in Preeclampsia: Vascular and Biomarker Implications

Overview of Extracellular Vesicles in the Pathogenesis of Preeclampsia

Placental extracellular vesicles from early-onset but not late-onset preeclampsia induce a pro-vasoconstrictive and anti-vasodilatory state in resistance arteries